IP Verse

Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic Cystitis - EP2034956

The patent EP2034956 was granted to Altergon on Jun 28, 2023. The application was originally filed on May 25, 2007 under application number EP07729534A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2034956

ALTERGON
Application Number
EP07729534A
Filing Date
May 25, 2007
Status
Patent Maintained As Amended
May 26, 2023
Grant Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STREHLKEDec 21, 2018- -

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTEP0136782
INTERNATIONAL-SEARCH-REPORTUS2004082540
INTERNATIONAL-SEARCH-REPORTWO03034993
INTERNATIONAL-SEARCH-REPORTWO2004034980
OPPOSITIONCA2269260
OPPOSITIONEP0136782
OPPOSITIONEP0971694
OPPOSITIONEP1124546
OPPOSITIONEP1365777
OPPOSITIONUS2004082540
OPPOSITIONUS4486416
OPPOSITIONUS5498606
OPPOSITIONUS5627162
OPPOSITIONUS6083933
OPPOSITIONUS6780841
OPPOSITIONWO0209728
OPPOSITIONWO03034993
OPPOSITIONWO2004034980
OPPOSITIONWO2006035969

Non-Patent Literature (NPL) Citations (64) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Aquivalent-Beispielrechnung zu Ausführungsbeispiel 12-
OPPOSITION- Aquivalent-Berechnungen zu den nachgereichten Versuchen der Patentinhaberin gemäss Dokument D39-
OPPOSITION- Aquivalent-Berechnungen zu den streitpatent gemässen Ausführungs beispielen-
OPPOSITION- "Chondroitin", Wikipedia, (20180624), pages 1 - 6-
OPPOSITION- "Chondroitin", Wikipedia, (20180624), pages 1 - 6, XP055544276-
OPPOSITION- Declaration Dr. Nadia Puppini, 15. May 2019-
OPPOSITION- E. CONSTANTINI et al., "Morphological Changes of Bladder Mucosa in Patients Who Underwent Instillation with Combined Sodium Hyaluronic Acid-Chondroitin Sul- phate (laluril®)", Urol. Int., (20130000), vol. 91, pages 81 - 88-
OPPOSITION- E. CONSTANTINI et al., "Morphological Changes of Bladder Mucosa in Patients Who Underwent Instillation with Combined Sodium Hyaluronic Acid-Chondroitin Sul- phate (laluril®)", Urol. Int., (20130000), vol. 91, pages 81 - 88, XP055544428-
OPPOSITION- EDOM - COUNCIL OF EUROPE, "European Pharmacopoeia - Chondroitin Sulfate Sodium”, 2017-
OPPOSITION- FRANCE SCA MACCARI et al., "Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects", Int. Urogynecol J., (20110000), vol. 22, pages 1581 - 1586-
OPPOSITION- G. STEINHOFF et al., "Chapter 45 The Efficacy of Intravesicular Sterile Sodium Chondroitin Sulfate 0,2% in Potassium Tested Positive Patients with Interstitial Cystitis", Bladder Disease: Research Concepts and Clinical Applications, (20030000), pages 731 - 739-
OPPOSITION- G. STEINHOFF et al., "Chapter 45 The Efficacy of Intravesicular Sterile Sodium Chondroitin Sulfate 0,2% in Potassium Tested Positive Patients with Interstitial Cystitis", Bladder Disease: Research Concepts and Clinical Applications, (20030000), pages 731 - 739, XP055544342-
OPPOSITION- G. STEINHOFF, "The Efficacy of Chondroitin Sulphate in Treating Interstitial Cystitis", European Urology Supplements, (20030000), vol. 2, pages 14 - 16-
OPPOSITION- "Hyaluronsäure", Wikipedia, (20181202), pages 1 - 7-
OPPOSITION- "Hyaluronsäure", Wikipedia, (20181202), pages 1 - 7, XP055544273-
OPPOSITION- Internet-Exzerpt gemäss https://www.acronymfinder.com/Molecular-Weiqht- (MW).html-
OPPOSITION- Internet-Exzerpt gemass https://www.ilpi.com/msds/ref/mole.html-
OPPOSITION- Internet-Exzerpt gemass https://wwwthoughtco.com/definition-of-molecularweight-605369. 6 Seiten-
OPPOSITION- "Interstitial cystitis", Wikipedia, (20150512), pages 1 - 13-
OPPOSITION- "Interstitial cystitis", Wikipedia, (20150512), pages 1 - 13, XP055544296-
OPPOSITION- "Interstitielle Zystitis", Wikipedia, (20150508), pages 1 - 2-
OPPOSITION- "Interstitielle Zystitis", Wikipedia, (20150508), pages 1 - 2, XP055544289-
OPPOSITION- J.B. Park und R.S. Lakes, "Biomaterials - An Introduction", Second Edition, Springer Science + Business Media. LLC.1992, Seiten 190 bis 192-
OPPOSITION- J.K. SHEEHAN et al., "Effect ofthe cations sodium, potassium and calcium on the interaction of hyaluronate chains: a light scattering and viscometric study", Int. J. Biol. Macromol., (19830000), vol. 5, pages 222 - 228-
OPPOSITION- JULIA EINBINDER et al., "Crystallization of Calcium Chondroitin Sulfate", J. Biol. Chem., (19510000), vol. 191, pages 591 - 597-
OPPOSITION- JULIA EINBINDER et al., "Crystallization of Calcium Chondroitin Sulfate", J. Biol. Chem., (19510000), vol. 191, pages 591 - 597, XP055544317-
OPPOSITION- MARY A. NAPIER et al., "Effect of calcium on structure and function of a hyaluronic acid matrix: Carbon-13 nuclear magnetic resonance analysis and the diffusional behavior of small solutes", Proc. Natl. Acad. Sci. USA, (19780500), vol. 75, no. 5, pages 2261 - 2265-
OPPOSITION- Page 21 of Opponent submission with annotations-
OPPOSITION- PAUL J. HAUSER et al., "Restoration of the Barrier Function to Acid-Damaged Bladder by Intravesical Chondroitin Sulfate", NIH Public Access Author Manuscript, (20091118), vol. 2, no. 5, pages 1 - 14-
OPPOSITION- Polymer Science Learning Center, "How Polymers Work Meaning of Molecular Weight" (cited 10.05.2019)-
OPPOSITION- R E Hurst, "Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract", World J. Urol., (19940000), vol. 12, pages 3 - 10-
OPPOSITION- Replica of D48 with different calculation method-
OPPOSITION- ROBERT E. HURST et al., "A Deficit of Chondroitin Sulfate Proteoglycans on the Bladder Uroepithelium in Interstitial Cystitis", Urology, (19960000), vol. 48, no. 5, pages 817 - 821-
OPPOSITION- ROBERT E. HURST et al., "Functional and structural characteristics of the glycosa- minoglycans of the bladder luminal surface", Pubmed, (19870800), vol. 138, no. 2, page 1-
OPPOSITION- ROBERT E. HURST et al., "Functional and structural characteristics of the glycosa- minoglycans of the bladder luminal surface", Pubmed, (19870800), vol. 138, no. 2, page 1, XP055544332-
OPPOSITION- ROBERT E. HURST et al., "Functional and structural characteristics of the glycosa- minoglycans of the bladder luminal surface", The Journal of Urology, (19870800), vol. 138, no. 2, pages 433 - 437-
OPPOSITION- R. PEEKER et al., "Treatment Guidelines for Classic and Non-Ulcer Interstitial Cystitis", Int. Urogynecol. J., (20000000), vol. 11, pages 23 - 32-
OPPOSITION- SABURO SHIMABAYASHI et al., "Interaction of Hydroxyapatite with Sodium Chondroitin Sulfate and Calcium Chondroitin Sulfate in an Aqueous Phase", Chem. Pharm. Bull., (19890600), vol. 37, no. 6, pages 1437 - 1440-
OPPOSITION- SABURO SHIMABAYASHI et al., "Interaction of Hydroxyapatite with Sodium Chondroitin Sulfate and Calcium Chondroitin Sulfate in an Aqueous Phase", Chem. Pharm. Bull., (19890600), vol. 37, no. 6, pages 1437 - 1440, XP002946440-
OPPOSITION- SAUL J. FARBER et al., "The Binding of Cations by Chondroitin Sulfate", J. Clin. Invest., (19570000), vol. 36, no. 12, pages 1715 - 1722-
OPPOSITION- SCOTT E.J., "Hyaluronan forms specific stable tertiary structures in aqueous solution A 13C NMR study", Proc. Natl. Acad. Sci. USA, (19990427), vol. 96, no. 9, pages 4850 - 4855-
OPPOSITION- SCOTT E.J., "Structure and function in extracellular matrices depend on interaction between anionic glycosaminoglycans", Pathol. Biol., (20010000), vol. 49, pages 284 - 289-
OPPOSITION- TIM HARDINGHAM, "Chapter 1 Solution Properties of Hyaluronan", TIM HARDINGHAM, Garg et al., Chemistry and Biology of Hyaluronan, Elsevier, (20040000), pages 1 - 19-
OPPOSITION- TIM HARDINGHAM, "Chapter 1 Solution Properties of Hyaluronan", TIM HARDINGHAM, Garg et al., Chemistry and Biology of Hyaluronan, Elsevier, (20040000), pages 1 - 19, XP055544264-
OPPOSITION- "Val (Einheit)", Wikipedia, pages 1 - 3-
OPPOSITION- "Val (Einheit)", Wikipedia, pages 1 - 3, XP055544285-
OPPOSITION- "Viskosimeter", Wikipedia, (20180808), pages 1 - 6-
OPPOSITION- "Viskosimeter", Wikipedia, (20180808), pages 1 - 6, XP055544282-
OPPOSITION- "Viskosität", Wikipedia-Exzerpt '', (20181211), page 9-
OPPOSITION- "Viskosität", Wikipedia-Exzerpt '', (20181211), page 9, XP055544278-
OPPOSITION- Volpi, Nicola, "Analytical Aspects of Pharmaceutical Grade Chondroitin Sulfates” Journal of Pharmaceutical Sciences, Vol. 96, No. 12, 12. December 2007-
OPPOSITION- Wikipedia-Exzerpt "Molmassenverteilung", 6 Seiten-
OPPOSITION- R E Hurst, "Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract", World J. Urol., (19940000), vol. 12, pages 3 - 10, XP055544345
OPPOSITION- R. PEEKER et al., "Treatment Guidelines for Classic and Non-Ulcer Interstitial Cystitis", Int. Urogynecol. J., (20000000), vol. 11, pages 23 - 32, XP001203848
OPPOSITION- FRANCE SCA MACCARI et al., "Fine structural characterization of chondroitin sulfate in urine of bladder pain syndrome subjects", Int. Urogynecol J., (20110000), vol. 22, pages 1581 - 1586, XP019972729
OPPOSITION- J.K. SHEEHAN et al., "Effect ofthe cations sodium, potassium and calcium on the interaction of hyaluronate chains: a light scattering and viscometric study", Int. J. Biol. Macromol., (19830000), vol. 5, pages 222 - 228, XP025215823
OPPOSITION- PAUL J. HAUSER et al., "Restoration of the Barrier Function to Acid-Damaged Bladder by Intravesical Chondroitin Sulfate", NIH Public Access Author Manuscript, (20091118), vol. 2, no. 5, pages 1 - 14, XP055544328
OPPOSITION- ROBERT E. HURST et al., "Functional and structural characteristics of the glycosa- minoglycans of the bladder luminal surface", The Journal of Urology, (19870800), vol. 138, no. 2, pages 433 - 437, XP055544336
OPPOSITION- ROBERT E. HURST et al., "A Deficit of Chondroitin Sulfate Proteoglycans on the Bladder Uroepithelium in Interstitial Cystitis", Urology, (19960000), vol. 48, no. 5, pages 817 - 821, XP055544350
OPPOSITION- SCOTT E.J., "Structure and function in extracellular matrices depend on interaction between anionic glycosaminoglycans", Pathol. Biol., (20010000), vol. 49, pages 284 - 289, XP055544268
OPPOSITION- G. STEINHOFF, "The Efficacy of Chondroitin Sulphate in Treating Interstitial Cystitis", European Urology Supplements, (20030000), vol. 2, pages 14 - 16, XP009040597
OPPOSITION- MARY A. NAPIER et al., "Effect of calcium on structure and function of a hyaluronic acid matrix: Carbon-13 nuclear magnetic resonance analysis and the diffusional behavior of small solutes", Proc. Natl. Acad. Sci. USA, (19780500), vol. 75, no. 5, pages 2261 - 2265, XP055544316
OPPOSITION- SCOTT E.J., "Hyaluronan forms specific stable tertiary structures in aqueous solution A 13C NMR study", Proc. Natl. Acad. Sci. USA, (19990427), vol. 96, no. 9, pages 4850 - 4855, XP055544270
OPPOSITION- SAUL J. FARBER et al., "The Binding of Cations by Chondroitin Sulfate", J. Clin. Invest., (19570000), vol. 36, no. 12, pages 1715 - 1722, XP055544305

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents